Abstract
Selective toxicity, i.e. differences in the biological consequences of drug action on normal and neoplastic cells, is the very basis of cancer chemotherapy, and the increasing effectiveness of drugs for the treatment of childhood leukemia, Burkitt’s lymphoma, choriocarcinoma, and some other types of neoplastic disease, demonstrates that such selectivity can be achieved even in man. However, the large number of patients who still die of malignant disease testify that selectivity of drug action is not attained with sufficient frequency or reliability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ball, C.R., Roberts, J.: DNA repair after mustard gas alkylation by sensitive and resistant Yoshida sarcoma cells in vitro. Chem. Biol. Interact. 2 321–329 (1970).
Bertino, J.R., Hillcoat, B.L.: Regulation of dihydrofolate reductase and other folate-requiring enzymes. Adv. Enzyme Regulat. 6 335–349 (1968).
Brockman, R.W.: Resistance to purine antagonists in experimental leukemia systems. Cancer Res. 25 1596–1605 (1965).
Chun, E.H.L., Gonzales, L., Lewis, F.S., Jones, J., Rutman, R. J.: Differences in the in vivo alkylation and cross-linking of nitrogen mustard-sensitive and -resistant lines of Leuré- Ehrlich ascites tumors. Cancer Res. 29 1184–1194 (1969).
Farber, E.: Biochemical pathology. Ann. Rev. Pharmacol. 11 71–96 (1971).
Farber, E., Baserga, R.: Differential effects of hydroxyurea on survival of proliferating cells in vivo. Cancer Res. 29 136–139 (1969).
Fernandes, J.F., LePage, G. A., Lindner, A.: The influence of azaserine and 6-mercaptopurine on the in vivo metabolism of ascites tumor cells. Cancer Res. 16 154–161 (1956).
Fisoher, G.A.: Defective transport of amethopterin as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. Biochem. Pharmacol. 11 1233–1234 (1962).
Gellhorn, A.: Laboratory and clinical studies on 8-azaguanosine. Cancer 6 1030–1033 (1953).
Goldenberg, G.J., Vanstone, C.L., Israels, L.G., Ilse, D., Bihler, I.: Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and -resistant L5178 Y lymphoblasts. Cancer Res. 30 2285–2291 (1970).
Guillino, P.M., Grantham, F.H., Smith, S.H., Haggerty, A.C.: Modifications of the acid-base status of the internal milieu of tumors. J. nat. Cancer Inst. 34 857–869 (1965).
Hakala, M.T.: On the role of drug penetration in amethopterin resistance of Sarcoma-180 cells in vitro. Biochim. biophys. Acta (Amst.) 102 198–209 (1965).
Hall, T.C., Roberts, D., Kessel, D.: Methotrexate and folic reductase in human cancer. Europ. J. Cancer 2 135–142 (1966).
Heidelberger, C., Kaldor, G., Mukherjee, K.L., Danneberg, P.B.: Studies on fluorinated pyrimidines. XI. In vitro studies on tumor resistance. Cancer Res. 20 903–909 (1960).
Henderson, J.F.: Variation in selective toxicity: Causes and consequences. Cancer Res. 29, 2404–2406 (1969).
Henderson, J.F., Caldwell, I.C., Paterson, A.R.P.: Decreased feedback inhibition in a 6-(methylmercapto)purine ribonucleoside-resistant tumor. Cancer Res. 27 1773–1778 (1967).
Henderson, J.F., LePage, G.A., McIver, F.A.: Observations on the action of azaserine in mammalian tissues. Cancer Res. 17 609–612 (1957).
Hennings, H., Devik, F.: Comparison of cytotoxicity of hydroxyurea in normal and rapidly proliferating epidermic and small intestine in mice. Cancer Res. 31 277–282 (1971).
Hirschberg, E., Kream, J., Gellhorn, A.: Enzymatic deamination of 8-azaguanine in normal and neoplastic tissues. Cancer Res. 12 524–528 (1952).
Ho, D.H.W., Luce, J.K., Frei, E.: Distribution of purine ribonucleoside kinase and selective toxicity of 6-methylthiopurine ribonucleoside. Biochem. Pharmacol. 17 1025–1035 (1968).
Jacquez, J.A.: Permeability of Ehrlich ascites tumor cells to folic acid, aminopterin and amethopterin. Cancer Res. 26 1616–1624 (1966).
Jacquez, J.A., Sherman, J.H.: Enzymatic degradation of azaserine. Cancer Res. 22 56–61 (1962).
Kahler, H., Robertson, W.B.: Hydrogen-ion concentration of normal liver and hepatic tumors. J. nat. Cancer Inst. 3 495–501 (1943).
Kessel, D., Hall, T.C.: Uptake and efflux of tritiated methotrexate by leukocytes. Clin. Res. 13 338 (1965).
Kessel, D., Hall, T.C.: Studies on drug transport by normal human leukocytes. Biochem. Pharmacol. 16 2395–2403 (1967).
Kessel, D., Hall, T.C.: Retention of 6-mercaptopurine derivatives by intact cells as an index of drug response in human and murine leukemias. Cancer Res. 29 2116–2119 (1969).
Kessel, D., Hall, T.C., Roberts, D.: Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response. Cancer Res. 28 564–570 (1968).
Kessel, D., Hall, T.C., Roberts, D., Wodinsky, I.: Uptake as a determinant of metho-trexate response in mouse leukemias. Science 150 752–754 (1965).
Kessel, D., Hall, T.C., Rosenthal, D.: Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro. Cancer Res. 29 459–463 (1969).
Klau, O., Stehlin, J.S., Jr., Mcbride, C., Griffin, A.C.: The effect of nitrogen mustard treatment on the deoxyribonucleic acid of sensitive and resistant Ehrlich tumor cells. Cancer Res. 29 286–290 (1969).
Kreis, W., Drahovsky, D., Borberg, H.: Characterization of protein and DNA in P815 cells sensitive and resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res. 32 696–701 (1972).
Krenitsky, T.A.: Tissue distribution of purine ribosyl- and phosphoribosyltransferases in the Rhesus monkey. Biochim. biophys. Acta (Amst.) 179 506–509 (1969).
LePage, G.A.: Alterations in enzyme activity in tumors and the implications for chemotherapy. Adv. Enzyme Regulat. 8 323–332 (1970).
Lieberman, M.W., Verbin, R.S., Landay, M., Liang, H., Farber, E., Lee, T.N., Starr, R.: A probable role for protein synthesis in intestinal epithelial cell damage induced in vivo by cytosine arabinoside, nitrogen mustard, or x-irradiation. Cancer Res. 30 942–951 (1970).
Lyons, R.M., Goldenberg, G.J.: Active transport of nitrogen mustard by normal and leukemic human lymphoid cells. Proc. Amer. Ass. Cancer Res. 13 15 (1972).
Marchesi, S.L., Sartorelli, A.C.: The biochemical basis for the differential sensitivity of intestinal mucosa and bone marrow to 6-thioguanine. Cancer Res. 23 1769–1773 (1963).
Moore, E.C., LePage, G.A.: In vivo sensitivity of normal and neoplastic mouse tissue to azaserine. Cancer Res. 17 804–808 (1957).
Moore, E.C., LePage, G.A.: The metabolism of 6-thioguanine in normal and neoplastic tissues. Cancer Res. 18 1075–1083 (1958).
Murray, A.W.: Purine-phosphoribosyltransferase activities in rat and mouse tissues and in Ehrlich ascites-tumor cells. Biochem. J. 100 664–670 (1966).
Nichol, C.A.: Studies on dihydrofolate reductase related to the drug sensitivity of microbial and neoplastic cells. Adv. Enzyme Regulat. 6 305–322 (1968).
Oliver, J.M., Paterson, A.R.P.: Nucleoside transport I. A mediated process in human erythrocytes. Canad. J. Biochem. 49 262–270 (1971).
Peery, A., LePage, G.A.: Nucleotide formation from α and β-2′-deoxythioguanosine in extracts of murine and human tissues. Cancer Res. 29, 617–623 (1969).
Pfeiffer, S.E., Tolmach, L. J.: Inhibition of DNA synthesis in HeLa cells by hydroxyurea. Cancer Res. 27 124–129 (1967).
Philips, F.S., Sternberg, S.S., Schwartz, H.S., Cronin, A.P., Sodergren, J.E., Vidal, P.M.: Hydroxyurea. I. Acute cell death in proliferating tissues in rats. Cancer Res. 27 61–74 (1967).
Poole, D.T., Butler, T. C., Waddell, W.J.: Intracellular pH of the Ehrlich ascites tumor cell. J. nat. Cancer Inst. 32 939–946 (1964).
Rall, D.P.: Selective aspects of chemotherapy in acute leukemia and Burkiu’s tumor. Cancer 21 575–579 (1968).
Roberts, D., Hall, T.C.: The reduction of folate and dihydrofolate by homogenates of leukocytes from patients with leukemia or with myeloid metaplasia. Cancer Res. 27 994–999 (1967).
Roberts, J.J., Crathorn, A.R., Brent, T.P.: Repair of alkylated DNA in mammalian cells. Nature (Lond.) 218 970–972 (1968).
Rosenbloom, F.M., Kelley, W.N., Miller, J., Henderson, J.F., Seegmiller, J.E.: Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical effects. J. Amer. med. Assoc. 202 175–177 (1967).
Rutman, R.J., Chun, E.H.L., Lewis, F.S.: Permeability difference as a source of resistance to alkylating agents in Ehrlich ascites tumor cells. Biochem. biophys. Res. Commun. 32 650–657 (1968).
Sartorelli, A.C.: Some approaches to the therapeutic exploitation of metabolic sites of vulnerability of neoplastic cells. Cancer Res. 29 2292–2299 (1969).
Sartorelli, A.C., LePage, G.A.: The development and biochemical characterization of resistance to azaserine in a TA3 ascites carcinoma. Cancer Res. 18 457–463 (1958).
Schwartz, H.S., Garofalo, M., Sternberg, S.S., Philips, F.S.: Hydroxyurea: Inhibition of deoxyribonucleic acid synthesis in regenerating liver of rats. Cancer Res. 25 1867–1870 (1965).
Sinclair, W.K.: Hydroxyurea: Effects on Chinese hamster cells grown in culture. Cancer Res. 27 297–308 (1967).
Sirotnak, F.M., Kurita, S., Hutchison, D.J.: On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia. Cancer Res. 28 75–80 (1968).
Skipper, H.E.: The cell cycle and chemotherapy of cancer. In: The cell cycle and cancer. New York: Marcel Dekker 1971.
Sneider, T.W., Pouer, V.R.: Alternative de novo and “salvage” pathways to thymidine triphosphate synthesis: Possible implications for cancer chemotherapy. Cancer Res. 29 2398–2403 (1969).
Walker, I. G., Reid, B. D.: Some properties of substrains of L-cells with a decreased sensitivity to bis(2-chloroethyl)sulfide. Cancer Res. 31 510–515 (1971).
Werkheiser, W.C., Law, L.W., Roosa, R.A., Nichol, C.A.: Further evidence that selective uptake modifies cellular response to 4-aminofolate antagonists. Proc. Amer. Ass. Cancer Res. 4 71 (1963).
Wolpert, M.K., Damle, S.R, Brown, J.E., Sznycer, E., Agrawal, K.C., Sartorelli, A.C: The role of phosphohydrolases in the mechanism of resistance of neoplastic cells to 6-thiopurines. Cancer Res. 31 1620–1626 (1971).
Wolpert, M.K., Ruddon, R. W.: A study on the mechanism of resistance to nitrogen mustard (HN2) in Ehrlich ascites tumor cells: Comparison of uptake of HN2–14C into sensitive and resistant cells. Cancer Res. 29 873–879 (1969).
Young, C.W., Schochetman, G., Karnopsky, D. A.: Hydroxyurea-induced inhibition of deoxyribonucleotide synthesis: Studies in intact cells. Cancer Res. 27 526–534 (1967).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Henderson, J.F. (1974). Biochemical Aspects of Selective Toxicity. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive